IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $26,000 | -72.3% | 589 | -64.5% | 0.00% | – |
| Q4 2020 | $94,000 | +118.6% | 1,658 | +75.1% | 0.00% | – |
| Q3 2020 | $43,000 | -42.7% | 947 | -25.6% | 0.00% | – |
| Q2 2020 | $75,000 | +5.6% | 1,272 | -8.6% | 0.00% | – |
| Q1 2020 | $71,000 | -93.6% | 1,392 | -92.5% | 0.00% | -100.0% |
| Q3 2019 | $1,101,000 | +18.4% | 18,647 | +62.7% | 0.00% | 0.0% |
| Q1 2019 | $930,000 | +43.5% | 11,460 | -4.4% | 0.00% | +100.0% |
| Q4 2018 | $648,000 | -10.7% | 11,984 | -14.9% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | +172.9% | 14,080 | +179.0% | 0.00% | – |
| Q3 2017 | $266,000 | -33.7% | 5,047 | -34.9% | 0.00% | -100.0% |
| Q2 2017 | $401,000 | – | 7,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |